title: Mefloquine in the treatment of cutaneous leishmaniasis.
abstract: Three cases of cutaneous leishmaniasis were treated orally with a mefloquine dose of 4.2 mg/kg/day for six days in the Teaching Hospital of the Faculdade de Medicina do Triângulo Mineiro, Uberaba, MG, Brazil. Three weeks later a new series was repeated. No patient was cured.
authors.affiliation: Disciplina de Doenças Infecciosas e Parasitárias, Faculdade de Medicina do Triângulo Mineiro, Uberaba, MG, Brasil. dalmo@mednet.com.br
authors.forename: D
authors.initials: D
authors.lastname: Correia
authors.forename: C A
authors.initials: CA
authors.lastname: Silva
authors.forename: A G
authors.initials: AG
authors.lastname: Matthes
mesh_terms: D000962:Antimalarials / Q000627:therapeutic use*; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy*; D015767:Mefloquine / Q000627:therapeutic use*
chemical_list: D000962:Antimalarials; D015767:Mefloquine